Biomerica, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
BMRA Nasdaq 3840 www.biomerica.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Biomerica, Inc.

Biomerica Announces Medicare Administrative Contractor Confirmation of Individual Claim Review for inFoods® IBS, Opening a Scalable Medicare Commercialization Pathway - Apr 16th, 2026 6:19 am
Biomerica Launches inFoods® IBS in Canada Through Partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs - Apr 14th, 2026 6:19 am
Biomerica Reports Third Quarter Fiscal 2026 Financial Results - Apr 13th, 2026 4:57 pm
Biomerica Receives First Commercial Order for its H. pylori test (Hp Detect™) from One of the Largest Clinical Laboratory Chains in Europe - Mar 18th, 2026 6:19 am
Biomerica Receives MHRA Registration for hp+detect™, Allowing Commercial Sales in Great Britain - Mar 5th, 2026 6:19 am
Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods® IBS Therapy - Feb 26th, 2026 6:19 am
Vietnam Approves Biomerica’s EZ Detect™ for Nationwide Distribution - Feb 18th, 2026 6:19 am
Biomerica Reports Second Quarter Fiscal 2026 Financial Results - Jan 14th, 2026 3:17 pm
Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test - Dec 23rd, 2025 6:19 am
Egyptian Drug Authority Authorizes Biomerica’s Complete Screening Test Portfolio - Dec 11th, 2025 6:08 am
Biomerica’s inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS - Nov 25th, 2025 6:19 am
Biomerica Expands Contract Development and Manufacturing Services to Meet Growing Market Demand - Nov 6th, 2025 6:19 am
How Biomerica Deal Expands Henry Schein’s (HSIC) Diagnostic Ambitions and Alters Its Investment Narrative - Oct 16th, 2025 6:23 pm
Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica’s inFoods® IBS Test in the U.S. - Oct 16th, 2025 6:19 am
Biomerica Reports First Quarter Fiscal 2026 Financial Results - Oct 15th, 2025 7:27 am
Gary Huff, Former CEO of LabCorp Diagnostics, Appointed to Biomerica Board of Directors - Oct 8th, 2025 6:19 am
Biomerica Launches AI-Backed inFoods® IBS Trigger Food Navigator to Support Personalized IBS Therapy and Improve Patient Outcomes - Sep 9th, 2025 6:08 am
United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Kidney Test for Home Use - Sep 3rd, 2025 6:19 am
Biomerica Reports Fiscal 2025 Year End Results - Aug 29th, 2025 3:12 pm
Biomerica receives approval in UAE for at-home ulcer test - Aug 18th, 2025 3:07 am